ProSci’s Custom Antibody Services were used to develop a mouse monoclonal antibody against cGAMP in a recent study.
Discovery Of PF-06928215 As A High-Affinity Inhibitor of cGAS Enabled by a Novel Fluorescence Polarisation Assay

ProSci’s Custom Antibody Services were used to develop a mouse monoclonal antibody against cGAMP in a recent study.
ProSci has generated several antibody reagents for SARS-CoV-2 research. Two of these antibodies were used in research by Yunguang Sun and colleagues.
Researchers at New York University Grossman School of Medicine, led by Erin E. Congdon, have explored the potential of single-domain antibodies (sdAbs) in treating tauopathies, including Alzheimer’s disease. The results of their study were recently published in The Lancet® and focused
At ProSci, custom polyclonal antibodies are generated in various host species from customised immunogens designed by expert antibody scientists.
As of May 2022, a highly contagious influenza virus continues to wreak havoc on domestic bird flocks across the United States. Millions of chickens and other fowl are dying or being killed to stop the spread of an HPAI (highly
Understanding binding affinity is an important part of the drug discovery process, ensuring that therapeutic antibodies that bind their targets selectively and specifically. It also helps to understand the intermolecular interactions driving biological processes, structural biology, and structure-function relationships. KD
Single Domain Antibodies (aka Nanobodies, VHH antibodies & camelid antibodies) are at the forefront of research in HIV, cancer, & other cell diseases.